The State of Biotech

Close to the Edge

What’s in Store for 2024? Three CEOs Look Ahead and Look Back on “Close to the Edge”

Space Race: 10x CEO Serge Saxonov Discusses Single Cell and Spatial Biology on “Close to the Edge”

Perfect Pitch: Genome Editing Pioneer Fyodor Urnov on Commercializing CRISPR Therapies and Epigenomic Tuning

BIO CEO Rachel King Outlines Industry’s Challenges on “Close to the Edge”

Carl Icahn States His Case for Change at Illumina on “Close to the Edge”

Front Row

GEN Edge Live